Nucleus Genomics
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $32.0Mattributed |
|---|---|
| Latest round | series-a, $14.0M, 2025-01-30attributed |
| Founded | 2021 |
| Headquarters | New York, US |
| Industry | bio |
| Stage | series-a |
| Website | mynucleus.com |
Nucleus Genomics provides whole-genome screening, prenatal genetic services, and embryo selection analysis for IVF patients. It serves couples planning families and the 165+ fertility clinics that partner with the company globally. The platform extends beyond disease risk into polygenic trait scoring covering eye color, height, and cognitive measures.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-30 | series-a | $14.0M | founders-fund |
Detected tech stack
Framer Sites, React 16.13.1, supabase, firebase
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $14.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Total raised $32.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Company existence | self-reported | mynucleus.com, read 2026-05-08 |
| Description | self-reported | mynucleus.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.